Enhanced mucosal antibody production and protection against respiratory infections following an orally administered bacterial extract
Secondary bacterial infections following influenza infection are a pressing problem facing respiratory medicine. Although antibiotic treatment has been highly successful over recent decades, fatalities due to secondary bacterial infections remain one of the leading causes of death associated with in...
Main Author: | Benjamin John Marsland |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-10-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fmed.2014.00041/full |
Similar Items
-
Systemic and Mucosal Antibody Responses to Soluble and Nanoparticle-Conjugated Antigens Administered Intranasally
by: Savannah E. Howe, et al.
Published: (2016-10-01) -
PREPARATION AND PROPERTIES OF MURINE ANTI-IDIOTYPIC MONOCLONAL ANTIBODIES RECOGNIZING PRIMARY RABBIT POLYCLONAL ANTIBODIES AGAINST MORPHINE DERIVATIVES
by: A. V. Trofimov, et al.
Published: (2019-12-01) -
POLYCLONAL ANTIBODY UTILIZATION FOR DETECTION OF JEMBRANA ANTIGEN AT BALI CATTLE IN WEST SUMATRA PROVINCE
by: Helmi Helmi, et al.
Published: (2020-04-01) -
Polyclonal antibodies inhibit growth of key cellulolytic rumen bacterial species
by: Sara M. Tondini, et al.
Published: (2023-06-01) -
Polyclonal antibody preparation against candidate tumour suppressor protein MIP for detection of its expression and localization in hepatocellular carcinoma
by: Minhua Wu, et al.
Published: (2017-11-01)